Casper has been active in venture capital investing since 2002. He has a broad experience in areas as diverse as materials, electronics, medtech and biotech.
He is a director of Chemelot Ventures and of its predecessor Limburg Ventures; next to this he is a Senior Investment Manager with DSM Venturing for a minor part of his time. In these capacities he was involved in a large number of investments and has acted as a board member and/or shareholder for multiple portfolio companies. He is currently chairman of the board of Pharmacell BV and member of the board of Kriya Materials, Basic Pharma and Isobionics.
Before his involvement in venture capital Casper held various positions in international BtB marketing, sales and new business development.
He studied Business Economics at Tilburg University (Netherlands) and Indiana University (Bloomington, USA).
- +31 6 2266 7882